This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Abbvie Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Innovations by Andrew J McCluskey
Introduction
Andrew J McCluskey is an accomplished inventor based in Holden, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 2 patents, his work focuses on addressing critical health issues, including Alzheimer's Disease.
Latest Patents
One of McCluskey's latest patents is titled "Anti-amyloid beta antibodies and methods of using the same." This inventive concept relates to antibodies, such as recombinant humanized and monoclonal antibodies, which are designed to specifically bind to and clear amyloid-beta (Aβ) plaques in the brain. These antibodies hold promise for the treatment of disorders such as Alzheimer's Disease (AD). Another notable patent is for "Anti-CCR8 antibodies," which provides compositions and methods for using these antibodies in various therapeutic contexts.
Career Highlights
Andrew J McCluskey is currently associated with AbbVie Inc., a leading biopharmaceutical company. His work at AbbVie focuses on innovative solutions to complex medical challenges, particularly in the realm of antibody development.
Collaborations
Throughout his career, McCluskey has collaborated with talented professionals, including Meha Chhaya and Amanda M Schmidt Paustian. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Andrew J McCluskey's contributions to the field of biotechnology through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to pave the way for advancements in the treatment of serious medical conditions.